Suppr超能文献

PPARα 激活后脂肪组织中氧化酶表达增加。

Increased expression of oxidative enzymes in adipose tissue following PPARα-activation.

机构信息

Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Department of Microbiology, Biological Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

出版信息

Metabolism. 2014 Apr;63(4):456-60. doi: 10.1016/j.metabol.2013.12.009. Epub 2013 Dec 25.

Abstract

OBJECTIVE

Evaluate the effect of fenofibrate treatment on the expression of PPARα and oxidative enzymes in adipose tissue.

MATERIALS/METHODS: Wistar male rats were fed a balanced diet supplemented with 100mg.Kg-1 bw.day-1 fenofibrate (Sigma) during nine days. Plasma glucose, free fatty acids (FFA) leptin and insulin were determined. PPARα, ACO and CPT-1 mRNA expression and amount of PPARα and PPARγ protein were assessed in epididymal adipose tissue. Oral glucose tolerance test was evaluated into overnight fasted rats. Glucose uptake was measured in adipocytes isolated from epididymal fat pads in the presence or absence of insulin (25ng/mL).

RESULTS

Fenofibrate treatment increased PPARα and PPARγ protein abundance in adipose tissue. In addition to it well- known effect on oxidative enzymes in liver, fenofibrate treatment also induces a high expression of Acyl CoA Oxidase (ACO) and Carnitine palmitoyltransferase 1 (CPT-1) in adipose tissue. Furthermore, we have shown that the fenofibrate treatment improves the glucose tolerance and enhance the glucose uptake by adipocytes.

CONCLUSION

Altogether, the data suggest that fenofibrate have a direct effect in adipose tissue contributing to the low adiposity and improvement of glucose homeostasis.

摘要

目的

评估非诺贝特治疗对脂肪组织中 PPARα 和氧化酶表达的影响。

材料/方法:将 Wistar 雄性大鼠用补充有 100mg.Kg-1 bw.day-1 非诺贝特(Sigma)的平衡饮食喂养 9 天。测定血浆葡萄糖、游离脂肪酸(FFA)、瘦素和胰岛素。评估附睾脂肪组织中 PPARα、ACO 和 CPT-1 mRNA 表达以及 PPARα 和 PPARγ 蛋白的含量。对 overnight 禁食的大鼠进行口服葡萄糖耐量试验。在存在或不存在胰岛素(25ng/mL)的情况下,测量从附睾脂肪垫分离的脂肪细胞中的葡萄糖摄取量。

结果

非诺贝特治疗增加了脂肪组织中 PPARα 和 PPARγ 蛋白的丰度。除了对肝脏中氧化酶的已知作用外,非诺贝特治疗还诱导脂肪组织中酰基辅酶 A 氧化酶(ACO)和肉碱棕榈酰转移酶 1(CPT-1)的高表达。此外,我们已经表明,非诺贝特治疗改善了葡萄糖耐量并增强了脂肪细胞的葡萄糖摄取。

结论

综上所述,这些数据表明,非诺贝特对脂肪组织具有直接作用,有助于降低脂肪含量和改善葡萄糖稳态。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验